Pharmaceutical Investing RINVOQ® Receives Health Canada Notice of Compliance for Giant Cell Arteritis in adults 6h
Pharmaceutical Investing AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline 25 August
Pharmaceutical Investing AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata 21 August
